Concerning their role in cancer treatment, MAO-A inhibitor monotherapy, or in combination with enzalutamide or docetaxel treatment, results in reduced proliferation and tumor growth in vitro and in vivo [16, 25, 40]. This evidence concerns the gene MAOA and neoplasm.